MEDICOVER Aktie

 

Medicover's (MCOV B) year-end and Q4 report 2024 will be published on 12 February at 07.45 CET. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CET. The report will be presented by CEO Fredrik Rågmark and CFO Anand Patel, followed by a Q&A session. Shortly before the webcast, presentation slides will be available on medicover.com (https://www.medicover.com/financial-information). If you wish to participate via audiocast please use the link below. Audiocast (https://medicover.events.inderes.com/q4-report-2024/register)...

Medicover has decided to exit the Hungarian market and disposes of its insurance operations in Hungary. Since 2013, Medicover has only operated its health insurance business in Hungary having no clinics or health provision activities. Medicover will also terminate its brand licensing used with Hungarian partner clinics providing services to members. The health insurance business will be transferred to another Hungarian health insurer and a transfer process has already been initiated in collaboration with the relevant authorities. The transition is expected to take approximately six...

Medicover has released its Social Finance Investor Report for 2024. The social finance framework was launched in 2021 and in connection with the launch €277m was raised in German schuldschein debt. The social financing framework is a use-of-proceeds structure and aims to contribute to the World Bank's Universal Health Coverage goals, ensuring that people have access to essential healthcare services. Lack of health infrastructure is one of the global development challenges and improving and increasing access for communities to affordable healthcare requires significant investments in...

The board of directors of Medicover AB (Publ) has today decided to evaluate the opportunity to list the Indian hospital subsidiary in India over the coming 12-24 months to further support its growth ambitions in the fast-growing Indian market. Medicover Hospitals India operates 23 hospitals and 2 cancer centres in four states (Andra Pradesh, Karnataka, Maharashtra and Telangana). Revenue in India for the last twelve months was €196.9 million at the end of Q3 2024. Medicover plans to open two new hospitals in 2025 and early 2026. If a listing takes place, the process is estimated to take...

BUZZ-Deutsche Bank starts Medicover with 'buy' on stable revenue, growth in Europe and India ** Shares of Swedish healthcare provider Medicover MCOVb.ST rise 0.9% to SEK 182.2 ** Deutsche Bank initiates coverage with a "buy" and TP of SEK 210, citing stable revenues, Central European growth, and strategies to counter German regulatory risks ** Says...

EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc., a global CRO, and Medicover Integrated Clinical Services (MICS), part of Medicover, an international healthcare and diagnos......

STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- Third quarter Revenue amounted to €527.8m (€440.5m), an increase of 19.8% with an organic growth of 17.4%. Operating profit (EBIT) was €6.7m (€18.5m), representing an operating margin of 1.3% (4.2%), impacted by an impairment charge of €-16.4m. Net......

Medicover's (MCOV B) Q3 report 2024 will be published on 30 October at 07.45 CET. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CET. The report will be presented by CEO Fredrik Rågmark, CFO Joe Ryan and successor Anand Patel, followed by a Q&A session. Shortly before the webcast, presentation slides will be available on medicover.com (https://www.medicover.com/financial-information). If you wish to participate via audiocast please use the link below. Audiocast (https://ir.financialhearings.com/medicover-q3-report-...

Medicover AB (publ) (“Medicover”) publishes the nomination committee's composition for the annual general meeting (“AGM”) in 2025. The nomination committee, which is appointed in accordance with the principles adopted by the annual general meeting on 26 April 2024, consists of: · Fredrik Stenmo, representing Celox Holding AB and the Christina af Jochnick family's total shareholding · Hans Ramel, NG Invest Beta AB · Jannis Kitsakis, Fjärde AP-Fonden · Sophie Larsén, AMF och AMF Fonder   The Board of Medicover AB (publ)   For more information, please visit:...

STOCKHOLM, Aug. 14, 2024 /PRNewswire/ -- Medicover AB (publ) has signed a letter of intent with Anand Patel to join Medicover as the Chief Financial Officer (CFO) and member of the Executive Management Team. Anand will join Medicover from October 1, 2024, with the handover of the role......

STOCKHOLM , July 25, 2024 /PRNewswire/ -- Second quarter Revenue amounted to €509.4m (€424.7m), an increase of 20.0% with an organic growth of 16.5%. Operating profit (EBIT) was €21.3m (€13.2m), an increase of 61.4%, representing an operating margin of 4.2% (3.1%). Net profit amounted to......

Medicover's (MCOV B) Q2 report 2024 will be published on 25 July at 07.45 CEST. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CEST. The report will be presented by CEO Fredrik Rågmark and CFO Joe Ryan and followed by a question-and-answer session. Shortly before the webcast, presentation slides will be available on medicover.com (https://www.medicover.com/financial-information). To access live webcast register here (https://ir.financialhearings.com/medicover-q2-report-2024). To dial in and ask questions register here (...